Dose-dependent effects of the caspase inhibitor Q-VD-OPh on different apoptosis-related processes

Journal of Cellular Biochemistry

Volumn 112, Issue 11, 2011, Pages 3334-3342

  Kuželová, Kateřina ^a   Grebeňová, Dana ^a   Brodská, Barbora ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

APOPTOSIS; IMATINIB; Q VD OPh; SAHA; z VAD fmk

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE INHIBITOR; FIBRONECTIN; IMATINIB; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; Q VC OPH; UNCLASSIFIED DRUG; VORINOSTAT;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DISRUPTION; CELL FRACTIONATION; DNA FRAGMENTATION; DOSE RESPONSE; ELECTROPHORESIS; ENZYME ACTIVITY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL ADHESION; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; QUINOLINES;

EID: 80054999734     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23263     Document Type: Article

References (35)

1. Braun JS, Prass K, Dirnagl U, Meisel A, Meisel C,. 2007. Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH. Exp Neurol 206: 183-191. (Pubitemid 47103174)
2. Brown NM, Martin SM, Maurice N, Kuwana T, Knudson CM,. 2007. Caspase inhibition blocks cell death and results in cell cycle arrest in cytokine-deprived hematopoietic cells. J Biol Chem 282: 2144-2155. (Pubitemid 47076766)
3. Caserta TM, Smith AN, Gultice AD, Reedy MA, Brown TL,. 2003. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 8: 345-352. (Pubitemid 36935206)
4. Chauvier D, Ankri S, Charriaut-Marlangue C, Casimir R, Jacotot E,. 2007. Broad-spectrum caspase inhibitors: From myth to reality ? Cell Death Differ 14: 387-391. (Pubitemid 46092244)
5. Chen J, Ramos J, Sirisawad M, Miller R, Naumovski L,. 2005. Motexafin gadolinium induces mitochondrially-mediated caspase-dependent apoptosis. Apoptosis 10: 1131-1142. (Pubitemid 41285588)
6. Colak A, Antar V, Karaoglan A, Akdemir O, Sahan E, Celik O, Sagmanligil A,. 2009. Q-VD-OPh, a pancaspase inhibitor, reduces trauma-induced apoptosis and improves the recovery of hind-limb function in rats after spinal cord injury. Neurocirugia (Astur) 20: 533-540; discussion 540.
7. DeBiasi RL, Robinson BA, Sherry B, Bouchard R, Brown RD, Rizeq M, Long C, Tyler KL,. 2004. Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol 78: 11040-11050. (Pubitemid 39299644)
8. Ekert PG, Silke J, Vaux DL,. 1999. Caspase inhibitors. Cell Death Differ 6: 1081-1086.
9. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES,. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 93: 7464-7469. (Pubitemid 26277057)
10. Goldstein JC, Rodier F, Garbe JC, Stampfer MR, Campisi J,. 2005. Caspase-independent cytochrome c release is a sensitive measure of low-level apoptosis in cell culture models. Aging Cell 4: 217-222. (Pubitemid 41602743)
11. Greco NJ, Seetharaman S, Kurtz J, Lee WR, Moroff G,. 2006. Evaluation of the reactivity of apoptosis markers before and after cryopreservation in cord blood CD34(+) cells. Stem Cells Dev 15: 124-135.
12. Han Z, Hendrickson EA, Bremner TA, Wyche JH,. 1997. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem 272: 13432-13436. (Pubitemid 27216778)
13. Koester SK, Roth P, Mikulka WR, Schlossman SF, Zhang C, Bolton WE,. 1997. Monitoring early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry 29: 306-312. (Pubitemid 28032097)
14. Koh DW, Dawson TM, Dawson VL,. 2005. Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 52: 5-14. (Pubitemid 40725595)
15. Kurokawa M, Kornbluth S,. 2009. Caspases and kinases in a death grip. Cell 138: 838-854.
16. Kuzelova K, Grebenova D, Hrkal Z,. 2007. Labeling of apoptotic JURL-MK1 cells by fluorescent caspase-3 inhibitor FAM-DEVD-fmk occurs mainly at site(s) different from caspase-3 active site. Cytometry A 71: 605-611. (Pubitemid 47221723)
17. Kuzelova K, Grebenova D, Pluskalova M, Kavan D, Halada P, Hrkal Z,. 2009. Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. J Cell Biochem 106: 673-681.
18. Kuzelova K, Pluskalova M, Brodska B, Otevrelova P, Elknerova K, Grebenova D, Hrkal Z,. 2010a. Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin. J Cell Biochem 109: 184-195.
19. Kuzelova K, Pluskalova M, Grebenova D, Pavlaskova K, Halada P, Hrkal Z,. 2010b. Changes in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cells. J Cell Biochem 111: 1413-1425.
20. Laemmli UK,. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
21. Lavallard VJ, Pradelli LA, Paul A, Beneteau M, Jacquel A, Auberger P, Ricci JE,. 2009. Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells. Cancer Res 69: 3013-3020.
22. Lecoeur H,. 2002. Nuclear apoptosis detection by flow cytometry: Influence of endogenous endonucleases. Exp Cell Res 277: 1-14. (Pubitemid 34948336)
23. Lidsky PV, Romanova LI, Kolesnikova MS, Bardina MV, Khitrina EV, Hato SV, van Kuppeveld FJ, Agol VI,. 2009. Interactions between viral and prokaryotic pathogens in a mixed infection with cardiovirus and mycoplasma. J Virol 83: 9940-9951.
24. Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD,. 2009. Sex differences in caspase activation after stroke. Stroke 40: 1842-1848.
25. Martin U, Jarasch N, Nestler M, Rassmann A, Munder T, Seitz S, Zell R, Wutzler P, Henke A,. 2007. Antiviral effects of pan-caspase inhibitors on the replication of coxsackievirus B3. Apoptosis 12: 525-533.
26. McStay GP, Salvesen GS, Green DR,. 2008. Overlapping cleavage motif selectivity of caspases: Implications for analysis of apoptotic pathways. Cell Death Differ 15: 322-331.
27. Nagahara Y, Tanaka M, Shinomiya T,. 2007. Mechanism of mitochondrial 7A6 antigen exposure triggered by distinct apoptotic pathways: Involvement of caspases. Cytometry A 71: 232-241. (Pubitemid 46581284)
28. Pop C, Salvesen GS,. 2009. Human caspases: Activation, specificity, and regulation. J Biol Chem 284: 21777-21781.
29. Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG,. 2009. Shiga toxin 2 targets the murine renal collecting duct epithelium. Infect Immun 77: 959-969.
30. Rebbaa A, Zheng X, Chou PM, Mirkin BL,. 2003. Caspase inhibition switches doxorubicin-induced apoptosis to senescence. Oncogene 22: 2805-2811. (Pubitemid 36609594)
31. Renolleau S, Fau S, Goyenvalle C, Joly LM, Chauvier D, Jacotot E, Mariani J, Charriaut-Marlangue C,. 2007. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: A role for gender. J Neurochem 100: 1062-1071. (Pubitemid 46213929)
32. Schrader K, Huai J, Jockel L, Oberle C, Borner C,. 2010. Non-caspase proteases: Triggers or amplifiers of apoptosis ? Cell Mol Life Sci 67: 1607-1618.
33. Soldani C, Scovassi AI,. 2002. Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update. Apoptosis 7: 321-328. (Pubitemid 34832256)
34. Vandenabeele P, Vanden Berghe T, Festjens N,. 2006. Caspase inhibitors promote alternative cell death pathways. Sci STKE 2006: pe44.
35. Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E, Joh TH, Beal MF,. 2004. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. Neurobiol Dis 17: 250-259. (Pubitemid 39345780)